neurodegenerative diseases

International clinical trial yields mixed results with unclear cognitive effects but promising biomarker results

New validation study shows potential use of neurofilament light chain in primary care settings 

National survey of MS specialists finds nearly 10 percent redeployed to the front lines of COVID-19 patient care

A novel method was the first to detect conformational changes in the TDP-43 protein in ALS patients' CSF

Targeting the mutated gene with the neuroprotective drug SynCav1 might halt or potentially prevent disease progression

Next-generation sequencing can identify known and novel genetic mutations that underlie complex neurological disorders

Using the terms as published for the different subtypes of MS and for describing disease activity is critical to improve care and clinical trials

Cellectricon offers fully validated in vitro disease models including human iPSC-derived neuronal cultures, cell lines, and native neuronal cultures

USC study shows Alzheimer's gene accelerates an inflammation pathway

Researchers have mapped out the cell types behind various brain disorders, finding that cells from the gut's nervous system are involved in Parkinson's disease